Pulmatrix Inc (PULM):企業の財務・戦略的SWOT分析

◆英語タイトル:Pulmatrix Inc (PULM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH135676FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pulmatrix Inc (Pulmatrix), formerly Ruthigen Inc is a clinical stage biopharmaceutical company that discovers and develops inhaled therapeutic products intended for prevention and treatment of respiratory diseases and infections. The company develops its pipeline products using its proprietary dry powder delivery technology, iSPERSE. Its pipeline products include PUR1900, an anti-fungal compound which is in Phase 1 clinical trials intended to treat allergic bronchopulmonary aspergillosis in severe asthmatics and cystic fibrosis patients; PUR1800, a narrow-spectrum kinase inhibitor intended for the treatment of patients with chronic obstructive pulmonary disease (COPD); PUR5700, for COPD, idiopathic pulmonary fibrosis and asthma; and PUR0200, a long-acting muscarinic antagonist drug candidate for COPD. Pulmatrix is headquartered in Lexington, Massachusetts, the US.

Pulmatrix Inc Key Recent Developments

Mar 23,2021: Pulmatrix Reports 2020 Financial Results and Provides Business Update
Feb 16,2021: Pulmatrix Announces Closing of $40 Million Registered Direct Offering
Feb 11,2021: Pulmatrix Announces $40 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Nov 12,2020: Pulmatrix reports third quarter 2020 financial results and business updates
Sep 29,2020: Pulmatrix strengthens Board of Directors with appointment of Todd Bazemore

This comprehensive SWOT profile of Pulmatrix Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Pulmatrix Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Pulmatrix Inc – Key Information
Pulmatrix Inc – Overview
Pulmatrix Inc – Key Employees
Pulmatrix Inc – Key Employee Biographies
Pulmatrix Inc – Key Operational Heads
Pulmatrix Inc – Major Products and Services
Pulmatrix Inc – History
Pulmatrix Inc – Company Statement
Pulmatrix Inc – Locations And Subsidiaries
Pulmatrix Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Pulmatrix Inc – Business Description
Pulmatrix Inc – Corporate Strategy
Pulmatrix Inc – SWOT Analysis
SWOT Analysis – Overview
Pulmatrix Inc – Strengths
Pulmatrix Inc – Weaknesses
Pulmatrix Inc – Opportunities
Pulmatrix Inc – Threats
Pulmatrix Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Pulmatrix Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Pulmatrix Inc, Key Information
Pulmatrix Inc, Key Ratios
Pulmatrix Inc, Share Data
Pulmatrix Inc, Major Products and Services
Pulmatrix Inc, History
Pulmatrix Inc, Key Employees
Pulmatrix Inc, Key Employee Biographies
Pulmatrix Inc, Key Operational Heads
Pulmatrix Inc, Other Locations
Pulmatrix Inc, Subsidiaries
Pulmatrix Inc, Key Competitors
Pulmatrix Inc, SWOT Analysis
Pulmatrix Inc, Ratios based on current share price
Pulmatrix Inc, Annual Ratios
Pulmatrix Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Pulmatrix Inc (PULM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • John Wiley & Sons, Inc.:企業のM&A・事業提携・投資動向
    John Wiley & Sons, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's John Wiley & Sons, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Fujifilm Corp:企業の戦略的SWOT分析
    Fujifilm Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Targa Resources Corp (TRGP):企業の財務・戦略的SWOT分析
    Targa Resources Corp (TRGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Daktronics Inc (DAKT):企業の財務・戦略的SWOT分析
    Daktronics Inc (DAKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bank Of Ningbo Co. Ltd.
    Bank Of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank Of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Trellis Bioscience Inc-製薬・医療分野:企業M&A・提携分析
    Summary Trellis Bioscience Inc (Trellis) is a healthcare services provider that offers therapies. The company discovers and develops human antibody therapeutics for the treatment of infectious diseases and cancer indications. It provides technology to defeat the deficiencies of current screening met …
  • Antaros Medical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Antaros Medical AB (Antaros Medical) is a drug development and technology company that offers innovative MRI and PET imaging techniques for decision making in clinical drug development. The company's services include small- to medium-sized studies, decision-making in Phase 1b and Phase 2 tri …
  • SPAGO Nanomedical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Spago Nanomedical AB (Spago Nanomedical), formerly Spago Imaging AB is a research and development company that develops nanomedical products for the diagnosis and treatment of cancer. The company offers spagopix, a magnetic resonance imaging contrast agent to improve the visualization of sof …
  • Faurecia SA (EO):企業の財務・戦略的SWOT分析
    Faurecia SA (EO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Albireo Pharma Inc (ALBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …
  • Cepheid:医療機器:M&Aディール及び事業提携情報
    Summary Cepheid, a subsidiary of Danaher Corporation, is a molecular diagnostic company that develops, manufactures and markets molecular systems and tests for clinical and non-clinical markets. The company offers in vitro diagnostic tests for health care associated infections, critical infectious d …
  • Olmsted Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Olmsted Medical Center (OMC) is a healthcare service provider that offers patient care and clinical research services. The center offers services in the areas of general surgery, podiatry, pain management, dermatology, plastic surgery, inpatient dietary services, pediatrics, diabetes educati …
  • Scope Metals Group Ltd:企業の戦略・SWOT・財務情報
    Scope Metals Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Scope Metals Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Intelsat S.A. (I):企業の財務・戦略的SWOT分析
    Intelsat S.A. (I) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sunrise Senior Living LLC:戦略・SWOT・企業財務分析
    Sunrise Senior Living LLC - Strategy, SWOT and Corporate Finance Report Summary Sunrise Senior Living LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • TECSYS Inc. (TCS):企業の財務・戦略的SWOT分析
    TECSYS Inc. (TCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Curis Inc (CRIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Curis Inc (Curis) is a biotechnology company that focuses on developing and commercializing novel drug candidates for treating human cancers with substantial unmet medical need. It has three drug candidates in development, CUDC-907 for diffuse large B-cell lymphoma (DLBCL) and solid tumors; …
  • EVRY ASA (EVRY):企業の財務・戦略的SWOT分析
    EVRY ASA (EVRY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Strong Petrochemical Holdings Ltd:企業の戦略・SWOT・財務情報
    Strong Petrochemical Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Strong Petrochemical Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • VERBIO Vereinigte BioEnergie AG (VBK):企業の財務・戦略的SWOT分析
    VERBIO Vereinigte BioEnergie AG (VBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆